واکسیناسیون به منظور ایجاد پایداری سلول های T دارای ژن اصلاح شده CD19CAR در کودکان مبتلا به لوکمی لنفوبلاستیک حاد       طراحی یک روش درمانی جدید در پیوند سلولهای بنیادی خونساز haploidentical با استفاده از idarubicin در ترکیب با ATG و basiliximab        ثبت نام رایگان ؛ثبت نام از کلیه فلوشیپهای خون و انکولوژی ،رزیدنتهای داخلی، رزیدنتهای عفونی، دانشجویان دکترای ژنتیک پزشکی....       آسیب اندوتلیال در GvHD حاد به عنوان عاملی جهت پیش بینی سیر پیشرفت        ایران میزبان کنگره پیوند مغز استخوان آسیا اقیانوسیه در سال 2017   صفحه اصلی   فرم ثبت نام   تماس با ما     English
Congress Programبرنامه کنگره

 

DETAILED PROGRAMME

 

 

DAY 1 – SATURDAY, 28 OCTOBER 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

SPEAKER

PROGRAMME

TIME

 

The Recitation of the Holy Quran , National Anthem of the Islamic Republic of Iran

7:30 – 8:00

Ardeshir Ghavamzadeh&Kamran Alimoghaddam

Welcome & Opening Remarks

8:00-8:30

Chairpersons: Ardeshir Ghavamzadeh &  Shinichiro Okomato

Plenary 1: APBMT/WBMT Joint Session: Transplantation  reports in asian pacific region & Progress of BMT in world and asian pacific region

8:30-10:00

Ardeshir Ghavamzadeh,Mani Ramzi & Mahshid Mehdizadeh

The report of transplantation in all BMT centers of Iran in five recent years(Tehran,Tabriz,Ahvaz, Sari,Kermanshah, Shiraz,Kerman, Babol, Mashhad,Urmia)

8:30-8:50

Shinichiro Okamoto

Current status and future challenges of Asia-Pacific Blood and Marrow Transplantation Group (APBMT)

8:50-9:10

Yoshihisa Kodera

The history, current status and future trends of WBMT

9:10-9:20

Huang He

The report of transplantation in china  in five recent years

9:20-9:30

Yoshihisa Kodera

Advance of HSCT after the enforcement of "The Act for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations" in Japan

9:30-9:40

 Lalindra Gooneratne

The report of transplantation in Sri Lanka  in five recent years

9:40-9:50

Aye Aye Gyi

The report of transplantation in  Myanmar  in five recent years

9:50-10:00

Ong Tee Chuan

The report of transplantation in  Malaysia  in five recent years

10:00-10:10

 

Tea Break

10:10-10:30

Chairpersons: Huang He, Kevin Hay

Plenary 2:Educational session of Immunotherapy in Transplantation Era: CART Cell

10:30-13:00

Kevin Hay

Toxicity of CAT therapy

10:30-10:50

Antonia Muller

New and old Targets for CART-Cell

10:50-11:10

Richard K. Burt

Advanced CD19-CART Therapy for acute lymphocytic leukemia and B cell Lymphoma/USA perspective

11:10-11:30

Kevin Hay

clinical experience with CD19 CAR for lymphoid malignancies

11:30-11:50

Huang He

Advanced CD19-CART therapy for acute lymphocytic leukemia and B cell Lymphoma/China Perspective

11:50-12:10

Huang He,Kevin Hay,Richard K. Burt,Antonia Muller

Panel Discussion

12:10-12:30

 

 

 

 

Pray& Lunch

12:30-14:00

 

 

 

Chairpersons:Raymond Leonard Powles, Mohamed Sorror

Plenary 3: Haploidentical and other related transplantation/MRD in post transplantation Era

14:00-16:00

Huang He

Haploidentical hematological stem cell transplantation as front line therapy for adult Acute Lymphocytic Leukemia

14:00-14:20

Raymond Leonard Powles

Place of Stem Cell Tranplants for accidental irradiation incidents

14:20-14:40

Mohamed Sorror

 Incorporating patient health in the decision-making about treatment of Acute Myeloid Leukemia

14:40-15:00

Mohammad Vaezi

Haploidentical Hematological stem cell transplantation reports of Hematology,Oncology and SCT Reserch Center of Iran

15:00-15:20

Koichi Miyamura

MRD in Philadephila Positive ALL patients post-transplant

15:20-15:40

Mohamed Sorror,Huang He,,Mohammad Vaezi,Koichi Miyamura

Panel Discussion

15:40-16:00

 

Tea Break

16:00-16:30

 

Poster Presentation

16:00-17:30

 

DAY2-SUNDAY, 29 OCTOBER 2017

 

SPEAKER

PROGRAMME

TIME

Chairpersons: Amir Ali Hamidieh,Amir Abbas Hedayati Asl

Plenary 4:Transplantation in Pediatrics & quality of HSCT

8:30-10:00

Amir Ali Hamidieh

 

8:30-8:50

Amir Abbas Hedayati Asl

Transplantation outcome  in  Pediatiric Philadelphia positive ALL patients

8:50-9:10

Tahereh Rostami

Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute B-Cell Lymphoblastic Leukemia Carrying High Risk Chromosomal Translocations: A Retrospective Single Center Study

9:10-9:25

Koichi Miyamura

Insurance approval of mesenchymal stem cell therapy for steroid refractory acute GVHD in Japan

9:25-9:45

Amir Ali Hamidieh,Amir Abbas Hedayati Asl,Tahereh Rostami

Panel Discussion

9:45-10:00

 

 

 

 

Tea Break

10:00-10:30

Chairpersons: Mehrdad Payandeh, Reiner Storb

Plenary 3: Transplantation in older and non malignant patients/MRD in Transplantation Era

10:30-13:00

Rainer Storb

Transplantation in older patients

10:30-10:50

Mohamed Sorror

 Comorbidities and Age in Allogeneic Hematopoietic Cell Transplantation

10:50-11:10

Rainer Storb

Transplantation for patients with non-malignant blood disorders

11:10-11:30

Koichi Miyamura

Persistent challenge of detection of minimal residual disease

11:30-11:50

Mehrdad Payandeh

Transplant in patients with comorbid disease

11:50-12:10

Mohamed Sorror,Rainer Storb,Mehrdad Payandeh,Koichi Miyamura,

Panel Discussion

12:10-12:30

 

 

 

 

Pray& Lunch

12:30-14:00

Chairpersons:Riccardo Saccaradi,Abbas Hajfathali,Mazyar Shadman

Plenary 4: Pre and Post transplantation treatment:{Allogeneic, Autologous, NK cell,DLI}

14:00-16:00

Hans Jochem Kolb

Prophylactic and pre-emptive DLI

14:00-14:20

Mazyar Shadman

Transplant for double or triple hit lymphoma and their management

14:20-14:40

Riccardo Saccaradi

HSCT for Multiple Sclerosis

14:40-15:00

Mazyar Shadman

Post transplant maintenance in lymphoid malignancies

15:00-15:20

Riccardo Saccaradi

International accreditation and quality of HSCT: the JACIE experience

15:20-15:40

Mazyar Shadman, Hans Jochem Kolb,Riccardo Saccaradi,Abbas Hajfathali

Panel Discussion

15:40-16:00

 

Tea Break

16:00-16:30

 

Poster Presentation

16:00-17:30

 

 

 

 

DAY3-MONDAY 30 OCTOBER 2017

 

SPEAKER

PROGRAMME

TIME

Chairpersons: Kamran Alimoghadam,Rainer Storb,Nicolas Kröger

Plenary 5: Educational Session of Cell therapy and regenerative medicine, GVHD and transplantation in non malignant diseases

8:30-10:00

Rainer Storb

graft-versus-host disease and graft-versus-tumor effects

8:30-8:45

Antonia Muller

Chronic GVHD and immune function post allo-HSCT

8:45-9:00

Nicolas Kröger

Treatment options for steroid refractory GvHD

9:00-9:15

Raymond Leonard Powles

Daratumumab in conjunction with ABMT(Cancer Centre London Experience)

9:15-9:30

Nicolas Kröger

Role of ATG in preventing GvHD after allogeneic SCT

9:30-9:45

Nicolas Kröger,Rainer Storb,Raymond Leonard Powles,Antonia Muller

Panel Discussion

9:30-10:00

 

 

 

 

Tea Break

10:00-10:30

Chairpersons: Seyed Asadollah Mousavi,Mohamad Vaezi, Hossein Kamranzadeh

Oral Presentations from submitted abstracts

10:30-13:00

Blank

Blank

10:30-10:50

Ali Unal

Successful treatment with granulocyte transfusion and early neutrophil engraftment in allogeneic transplant patients with febrile neutropenia

10:50-11:10

Alireza Ardjmand

Novel minimal residual disease marker sets for pediatric B-precursors acute lymphoblastic leukemia

11:10-11:30

Blank

Oral selected articles

11:30-11:50

Blank

Oral selected articles

11:50-12:10

 

Panel Discussion

12:10-12:30


سخنرانان مدعو
پیام رئیس کنگره

We are delighted to welcome you to the congress of the APBMT inTehran, Iran, 2017.

It is our great pleasure to invite you to participate in the next APBMT conference which will be held in Tehran, Iran 28-30 oct 2017 . The APBMT conference is a great opportunity to bring together scholars from the Asia pacific region to communicate and exchange ideas in order to improve the outcome of HSCT.We are honored to have invited well-known and esteemed scientists whose work, research and efforts need no introduction.Now I would like to draw your attention to a brief overview over beauties of Iran and events organized successfully by Iranian society of stem cell transplant. Our research institute actively involved in arranging important national and international conferences in hematology oncology and stem cell transplantation such as APBMT conference which was held in Tehran in 2004 and APCC conference in 2007. We are looking forward to meeting you in Tehran

Prof. Ardeshir Ghavamzadeh
President of the Congress

 

ورود اعضا
نام کاربری :
کلمه عبور :
 
  کلمه عبور خود را فراموش کرده ام.
فرم ثبت نام در کنگره راهنمای ارسال خلاصه مقاله لیست کارگاه های کنگره معرفی کنگره
درباره ایران
اخبار
عضویت در خبرنامه
حامیان کنگره
لطفا ایمیل خود را جهت دریافت خبرنامه وارد کنید
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
آمار بازديدها
تماس با ما
روز شمار
امروز 237
ماه جاری 11233
کل مراجعات 24120
نشانی: تهران،خيابان جلال آل احمد،بيمارستان شريعتي،مركز تحقيقات هماتولوژي،انكولوژي و پيوند سلولهاي بنيادي،انجمن پيوند سلولهاي بنيادي خونساز ايران
تلفن: 02184902668 2184902662 02184902635
فکس: 02188004140
رایانامه: info@apbmt2017.org